July 2, 2019

Valsartan Patient Sues Generic Drug Makers after Liver Cancer Diagnosis

Valsartan Patient Sues Generic Drug Makers after Liver Cancer Diagnosis

Product liability lawsuits against generic valsartan manufacturers continue to file in at an alarmingly rapid rate as more patients seek compensation for useless drugs, medical monitoring, and serious injuries caused by impure valsartan. One lawsuit filed in the U.S. District Court for the District of New Jersey alleges that valsartan patient James Moss’s liver cancer was caused by his recalled valsartan drugs.

Filed on June 20, Moss’s complaint lists the following valsartan manufacturers as defendants:

  • Zhejiang Huahai Pharmaceutical, Co.
  • Prinston Pharmacetuical
  • Solco Healthcare
  • Walgreens Boots Alliance.

In the claim Moss states that to treat his high blood pressure he began taking VCDS, or generic valsartan-containing drugs, in 2016. He continued to do so until the FDA released notice that generic valsartan may be tainted with cancer-causing drug impurities in July of 2018; Moss stopped taking the medication after hearing of the recall. These cancer-causing chemicals include Nitroso-dimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), both of which have been found at unusually high levels in batches of generic valsartan since as early as 2014.

Moss claims that months before the FDA released their notice of the recall, he was diagnosed with liver cancer, known as recurrent hepatocellular carcinoma, in February of the same year. Due to the diagnosis, Moss needed to undergo surgeries in May and October of 2018 and still needs a liver transplant. In the lawsuit, the plaintiff claims that the defendants knew for years about the harmful qualities of the chemical byproducts created by their manufacturing process and did nothing to adequately warn or inform the public of the risks of taking tainted valsartan.

“Plaintiff James Moss would not have consented to taking the [valsartan] at issue, had he known of or been fully and adequately informed by Defendants of the true increased risks and serious dangers of taking the drugs, which were rendered unreasonably dangerous by the presence of NDMA, NDEA, or other nitrosamines,” the lawsuit says.

Moss’s lawsuit is part of the Valsartan NDMA Products Liability Litigation consolidated in the District of New Jersey before the Honorable Robert B. Kugler. Many of the lawsuits within this litigation are seeking financial compensation to reimburse patients for the cost of impure, worthless drugs and for possible necessary medical monitoring.

Recent Posts

22 People Hospitalized from Vaping-Linked Breathing Issues, but Doctors Unsure of Why

Nearly two dozen people have been hospitalized in the Midwest with serious breathing difficulties linked to vaping. However, doctors can’t pinpoint the answer why. NBC News reports doctors are struggling to identify what the patients—mostly young adults—inhaled or used as a vaping device. Additionally, medical officers have not been able to identify where patients purchased […]

Read More
FDA Vaping Seizures Investigation Uncovers 127 Cases Over Last Decade

Federal investigators discovered far more reports of seizures linked to vaping e-cigarettes than originally anticipated. On August 7, the FDA issued a press release stating their scientific investigation uncovered 127 reports of seizures linked to vaping electronic cigarettes. This number far surpasses the original number of 35 reports since 2010. The FDA launched their investigation […]

Read More
Report of $8 Billion Roundup Settlement Dismissed by Bayer Mediator

The attorney in charge of mediating the Roundup weedkiller litigation in the United States rejected reports of Bayer AG paying $8 billion to settle all Roundup weedkiller claims in the US. “Such a statement is pure fiction,” Feinberg asserted in an email on Friday. “Compensation has not even been discussed in the global mediation discussions.” […]

Read More

Contact Us Today!

1. We're on Your Side

2. We're Available 24/7

3. No Fees Unless You Win
ATTORNEY ADVERTISEMENT: Not available in all states, Andrew Van Arsdale, supervising attorney is licensed only in California and Nevada, but associates with attorneys throughout the country, Principal office: 3667 Voltaire Street, San Diego, California 92106. 

Consult a doctor on all medical decisions. Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death. No representation is made that the quality of the legal services performed is greater than the quality of the legal services performed by other lawyers. AVA Law Group, Inc. not accepting cases in states where this advertising conflicts with laws or state rules. Legal representation is not offered or available in Tennessee. While AVA Law Group, Inc. maintains joint responsibility, most cases are referred to other attorneys for principal responsibility.
© Copyright 2019 
Privacy PolicyTerms of Use
twitter-squarefacebook-squarephoneyoutube-playenvelopephone-handsetmap-marker